Our Company was originally incorporated under the Companies Act, 1956 vide certificate of incorporation dated July 23, 2008 issued by the Registrar of Companies, Mumbai. Later in the year 2016, the name of the company was changed from ―Sudarshan Specialty Chemsolve Private Limited‖ to ―Sudarshan Pharma Industries Private Limited‖ under the Companies Act, 2013 pursuant to a special resolution passed by our shareholders at the EGM held on November 25, 2016 and vide certificate of incorporation dated December 17, 2016 issued by the Registrar of Companies, Mumbai. Thereafter, Our Company was converted in to a public company pursuant to a special resolution passed by our shareholders at the EGM held on December 12, 2016 and consequently name was changed to ―Sudarshan Pharma Industries Limited‖ (SPIL) vide fresh certificate of incorporation dated January 15, 2017 issued by Registrar of Companies, Mumbai. The CIN of the Company is U51496MH2008PLC184997.
Our company was promoted by Mr. Hemal V. Mehta & Mr. Sachin V. Mehta. Our promoters have a combined experience of over 25 years in the Special Chemical, Bulk drug and Pharmaceutical Industry. Driven by passion for building an integrated chemical and pharmaceutical company, backed by their more than two decades of individual experience, our Promoters have been the pillars of our Company`s growth since inception and have built a strong value system for our Company. With their enriching experience and progressive thinking, we aim to continue to grow in the chemical and pharmaceutical industry in India and abroad.
Our company was promoted by Mr. Hemal V. Mehta & Mr. Sachin V. Mehta. Our promoters have a combined experience of over 25 years in the Special Chemical, Bulk drug and Pharmaceutical Industry. Driven by passion for building an integrated chemical and pharmaceutical company, backed by their more than two decades of individual experience, our Promoters have been the pillars of our Company`s growth since inception and have built a strong value system for our Company. With their enriching experience and progressive thinking, we aim to continue to grow in the chemical and pharmaceutical industry in India and abroad.
Sudarshan Pharma Industries Ltd IPO Details
|
|
---|---|
Issue Open | 12-06-2019 |
Issue Close | 24-06-2019 |
Allotment Date | 30-06-2019 |
Unblocked Amount | 01-07-2019 |
Listing Date | 02-07-2019 |
Issue Share | 34,40,000 Total Equity Share 1,76,000 Reserved by Market Maker 32,64,000 Equity Share |
Issue Size | ₹ 25.80 Cr |
IPO Price Band | ₹ 75 |
Minimum Share Bid [Lost Size] | 1600 |
Minimum Investment Amount [Rs] | ₹ 1,20,000 |
Face Value | ₹ 10 |
Retail Allocation | 50% |
Listing On | NSE SME |
Sudarshan Pharma Industries Ltd IPO Grey Market Premium GMP]
|
||||
---|---|---|---|---|
Latest Update | Premium | Kostak | Subject to Sauda | Recommended |
02-06-2019 : 08:00 PM | - | - | - | - |
Sudarshan Pharma Industries Ltd IPO Financial details [in Rs, Cr]
|
||||
---|---|---|---|---|
Financial Year | Total Assets | Total Revenue | Total Expenses | Profit After Tax |
FY-2014 | - | - | - | - |
FY-2015 | - | - | - | - |
FY-2016 | 8.27 | 37.95 | 37.80 | 0.09 |
FY-2017 | 19.93 | 55.72 | 55.26 | 0.15 |
FY-2018 | 30.97 | 89.76 | 88.77 | 0.73 |
30-09-2018 | 51.90 | 60.70 | 58.68 | 1.45 |
Sudarshan Pharma Industries Ltd IPO Valuation Details
|
|
---|---|
Earnings Per Share [EPS] | ₹ 1.82 |
Price/Earnings [P/E] Ratio | 41.21 |
Return on Net Worth [RoNW] | 14.58 % |
Net Asset Value [NAV] | ₹ 12.46 Per Share |
Sudarshan Pharma Industries Ltd IPO Subscription Details
|
|||
---|---|---|---|
As on Date | QIB/NII | RII | Total |
Shared Offered | 16,32,000 | 16,32,000 | 32,64,000 |
Day-1 [12-06-2019] | 1,87,200 [0.11] | 62,400 [0.04] | 2,49,600 [0.08] |
Day-2 [13-06-2019] | 1,90,400 [0.12] | 2,89,600 [0.18] | 4,80,000 [0.15] |
Day-3 [14-06-2019] | 2,16,000 [0.13] | 5,18,400 [0.32] | 7,34,400 [0.23] |
Day-4 [17-06-2019] | 2,48,000 [0.15] | 12,44,800 [0.76] | 14,92,800 [0.46] |
Day-5 [18-06-2019] | 2,54,400 [0.16] | 12,44,800 [0.76] | 14,99,200 [0.46] |
Day-6 [19-06-2019] | 2,54,400 [0.16] | 12,49,600 [0.77] | 15,04,000 [0.47] |
Day-7 [20-06-2019] | 2,54,400 [0.16] | 12,62,400 [0.77] | 15,16,800 [0.47] |
Day-8 [21-06-2019] | 2,78,400 [0.17] | 12,54,400 [0.77] | 15,32,800 [0.47] |
Day-9 [24-06-2019] | - [-] | - [-] | - [-] |
Day-4 [-] | - [-] | - [-] | - [-] |
Sudarshan Pharma Industries Ltd IPO Grey Market Premium
|
---|
Check Grey Market Premium :- Click Here |
Sudarshan Pharma Industries Ltd IPO Allotment Status
|
---|
Check Allotment Status :- Click Here |
Live Subscription for Sudarshan Pharma Industries Ltd IPO
|
---|
Check Live Subscription :- Click Here |
Download Sudarshan Pharma Industries Ltd IPO DRHP & ASBA e-Forms
|
---|
Download DRHP :- Click Here to Download Download e-Forms NSE:- Click Here to Download |
Sudarshan Pharma Industries Ltd IPO Recommendations
|
---|
Live IPO Team Recommendation:- Neutral |
Sudarshan Pharma Industries Ltd IPO Contact Details
|
---|
Sudarshan Pharma Industries Ltd
301, 3rd Floor, Aura Biplex, Above Kalyan Jewellers, S V Road, Borivali (West), Mumbai – 400 092, Maharashtra, India, Tel. No.: +91 22 242221111 Email: compliance.spil@gmail.com Website: www.sudarshanpharma.com |
Registrar of Sudarshan Pharma Industries Ltd IPO
|
---|
Karvy Fintech Private Limited
Karvy Selenium Tower B, Plot 31-32, Gachibowli, Financial District, Nanakramguda, Hyderabad 500 032 India Tel. No.: 1-800-3454001/ +91 40 6716 2222 Fax No.: +91 40 2343 1551 E-mail: einward.ris@karvy.com Investor Grievance Email: spil.ipo@karvy.com Website: www.karisma.karvy.com Contact Person: Mr. M Murali Krishna SEBI Registration No.: INR000000221 |
Lead Managers of Sudarshan Pharma Industries Ltd IPO
|
---|
FIRST OVERSEAS CAPITAL LIMITED
1-2 Bhupen Chambers, Ground Floor, Dalal Street, Mumbai-400 001 Tel. No.: +91 22 40509999 Fax No.: N.A. Email: rushabh@focl.in/ satish@focl.in/ mala@focl.in Investor Grievance Email: investorcomplaints@focl.in Website: www.focl.in Contact Person: Mr. Rushabh Shroff/ Mr. Satish Sheth/ Ms. Mala Soneji SEBI Registration No.: INM000003671 |
Disclaimer:-
|
---|
• I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO.
• www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk
• We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO.
• Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.
|
0 Response to "Sudarshan Pharma Industries Ltd IPO Details"
Post a Comment